30 apr 2019
The board has proposed a rights issue to start addressing large markets in diabetes and oncology care. We see signs of increased growth and news flow as supportive for the shares.
Read the full report (Swedish) here.
Vi använder oss av cookies för att garantera dig den bästa upplevelsen av vår hemsida. Mer info
Jag godkänner!